Ventac Studio raised over 1.4B USD in venture capital funding.

Ventac Studio fast-tracks world-class science into de-risked life science companies. We source and evaluate high-potential research projects from universities, research institutions and global innovation networks, with a focus on therapeutics and supporting platforms. Through a startup studio model, we combine AI-supported sourcing, scientific due diligence, operational execution and hands-on company building to transform breakthrough science into investable NewCos with a disciplined path toward seed financing, IND-readiness and Series A. Ventac Studio bridges the gap between academic innovation and venture-ready biotech companies.